Principal Financial Group
REPL icon

Principal Financial Group’s Replimune Group REPL Stock Holding History

Principal Financial Group’s Portfolio REPL Stock Details REPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-13,129
Closed -$107K – 2440
2024
Q1 		$107K Sell
13,129
-1,571
-11% -$12.9K ﹤0.01% 2265
2023
Q4 		$124K Sell
14,700
-48
-0.3% -$557 ﹤0.01% 2237
2023
Q3 		$252K Buy
14,748
+2,165
+17% +$42.5K ﹤0.01% 2106
2023
Q2 		$292K Sell
12,583
-59
-0.5% -$1.15K ﹤0.01% 2083
2023
Q1 		$223K Buy
12,642
+2,211
+21% +$52.6K ﹤0.01% 2155
2022
Q4 		$284K Buy
+10,431
New +$217K ﹤0.01% 2120
2021
Q4 		– Sell
-9,232
Closed -$274K – 2611
2021
Q3 		$274K Sell
9,232
-1,499
-14% -$48.7K ﹤0.01% 2338
2021
Q2 		$412K Buy
+10,731
New +$367K ﹤0.01% 2265
2021
Q1 		– Sell
-6,025
Closed -$230K – 2500
2020
Q4 		$230K Buy
+6,025
New +$251K ﹤0.01% 2288

Other funds holding REPL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Principal Financial Group's REPL Position: Q2 2024 in Review

Principal Financial Group sold out of Replimune Group (REPL) in Q2 2024, closing a stake of 13,129 shares — an estimated $107K sold.

Principal Financial Group first reported a position in REPL in Q4 2020 and held it in 9 quarters. The position peaked at $412K in Q2 2021. 149 funds tracked by Wall St. Rank hold REPL as of Q2 2024.

  • Principal Financial Group reported no remaining Replimune Group position as of Q2 2024 after selling out during the quarter.
  • Principal Financial Group sold 13,129 Replimune Group shares in Q2 2024, an estimated $107K.
  • Principal Financial Group first reported a position in Replimune Group in Q4 2020 and held it in 9 quarters.
  • Principal Financial Group's Replimune Group position peaked at $412K in Q2 2021.
  • 149 funds tracked by Wall St. Rank held Replimune Group as of Q2 2024.

Based on Principal Financial Group's 13F filing for Q2 2024, filed 29 Jul 2024.